Catalog No.
Product Name
Application
Product Information
Citations
-
Ferroptosis Inhibitor
Isoeugenol acetate is a ferroptosis inhibitor derived from isoeugenol. This compound has been shown to modulate cell death mechanisms associated with oxidative stress, making it a valuable tool for investigating ferroptosis in various biological contexts. Its applications extend to research in cancer biology, neurodegenerative diseases, and other conditions where ferroptosis plays a critical role. -
Ferroptosis Inducer
WMK-1 is a 1,2,4,5-tetraoxane derivative that functions as a potent ferroptosis inducer. It exhibits significantly greater cytotoxicity towards cancer cells compared to non-cancerous cells, effectively triggering ferroptosis in both cancer cells and cancer stem cells. This compound is valuable for research focused on cancer biology and therapeutic strategies targeting ferroptosis. -
Ferroptosis Inducer
WMK-2 is a 1,2,4,5-tetraoxane derivative that functions as a ferroptosis inducer, demonstrating broad-spectrum anticancer activity. Its mechanism involves the generation of hydroxyl radicals and lipid reactive oxygen species (ROS), leading to ferroptosis in cancer cells and cancer stem cells. This compound serves as a valuable tool for research focused on cancer biology and therapeutic strategies targeting ferroptosis. -
Ferroptosis Inducer
Tralopyril is a potent ferroptosis inducer that selectively targets the thyroid hormone system and mitochondrial oxidative phosphorylation pathways. It promotes ferroptosis by downregulating key transcription factors such as TRHR, Nkx2.1, and TRα, thereby disrupting amino acid, energy, and lipid metabolism. Despite its primary application as an antifouling insecticide, its significant toxicity to skeletal and reproductive systems, alongside its implications for developmental damage, renders it useful in toxicological studies. Tralopyril's long half-life in vivo and broad tissue distribution highlight potential risks to both aquatic organisms and human health. -
intracellular iron chelating agent
Dexrazoxane monohydrochloride is the hydrochloride form of Dexrazoxane, primarily acting as an iron chelator and apoptosis inducer. This compound exhibits significant cardioprotective, anti-inflammatory, antioxidant, anti-tumor, and neuroprotective properties, making it a valuable tool in research. It is commonly utilized for studying cardiac protection during chemotherapy, as well as mechanisms of ferroptosis inhibition.

